Susceptibility of human T cell leukemia virus type I to nucleoside reverse transcriptase inhibitors
- PMID: 12870124
- DOI: 10.1086/376531
Susceptibility of human T cell leukemia virus type I to nucleoside reverse transcriptase inhibitors
Abstract
A single-cycle infection assay with recombinant viral vectors was developed to study human T cell leukemia virus type I (HTLV-I) replication and its inhibition by antiviral agents. The susceptibility of HTLV-I to 6 nucleoside reverse-transcriptase inhibitors was examined. HTLV-I replication was inhibited by tenofovir, abacavir, lamivudine, zalcitabine, stavudine, and zidovudine.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
